Research advances in primary biliary cholangitis with dyslipidemia / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 151-156, 2024.
Article
в Zh
| WPRIM
| ID: wpr-1006441
Ответственная библиотека:
WPRO
ABSTRACT
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive and non-purulent inflammation of small- and medium-sized bile ducts in the liver. Recent studies have shown that abnormal lipid metabolism is relatively common in patients with PBC, and 76% of PBC patients have dyslipidemia. The effects and harms of dyslipidemia have attracted much attention. Lipid metabolism disorders play an important role in the progression of PBC. This article mainly reviews the research advances in the manifestation, role, diagnosis, and treatment of lipid metabolism disorders in PBC, so as to provide new ideas for the treatment of PBC.
Полный текст:
1
База данных:
WPRIM
Язык:
Zh
Журнал:
Journal of Clinical Hepatology
Год:
2024
Тип:
Article